Lillie McCray (R) receives the Pfizer-BioNTech vaccine against coronavirus disease (COVID-19) from Walgreens healthcare professional Ghassan Ayyad (L) at the Victor Walchirk Apartments in Evanston, Illinois, February 22, 2021.
Kamil Krzaczynski | Reuters
The supply of Covid-19 vaccine in the United States is slated to substantially ramp up next month with manufacturers doubling the pace of production, company executives said in prepared remarks to be delivered to Congress on Tuesday.
Pfizer expects to provide more than 13 million doses of its two-shot vaccine per week to the U.S. by mid-March, more than double the weekly number of doses the company was sending earlier this month, Pfizer’s Chief Business Officer John Young said in written testimony. The testimony was released ahead of a hearing before the House Committee on Energy and Commerce.
Young also said Pfizer is on track to deliver 120 million doses by the end of March, with an additional 80 million doses to go out by the end of May.
Moderna President Dr. Stephen Hoge said his company is similarly working to double its shipments to the U.S. by April, according to Hoge’s prepared testimony. Moderna hopes to deliver 40 million doses per month, roughly double the current pace, he said…